These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Prophylactic low-energy shock wave therapy improves wound healing after vein harvesting for coronary artery bypass graft surgery: a prospective, randomized trial. Dumfarth J; Zimpfer D; Vögele-Kadletz M; Holfeld J; Sihorsch F; Schaden W; Czerny M; Aharinejad S; Wolner E; Grimm M Ann Thorac Surg; 2008 Dec; 86(6):1909-13. PubMed ID: 19022007 [TBL] [Abstract][Full Text] [Related]
8. The effect of cephalothin prophylaxis on postoperative ventriculoperitoneal shunt infections. Rieder MJ; Frewen TC; Del Maestro RF; Coyle A; Lovell S CMAJ; 1987 May; 136(9):935-8. PubMed ID: 3552176 [TBL] [Abstract][Full Text] [Related]
9. Aortocoronary bypass procedures and sternotomy infections: a study of antistaphylococcal prophylaxis. Austin TW; Coles JC; Burnett R; Goldbach M Can J Surg; 1980 Sep; 23(5):483-5. PubMed ID: 6969109 [TBL] [Abstract][Full Text] [Related]
10. Reduction of sternal infection by application of topical vancomycin. Vander Salm TJ; Okike ON; Pasque MK; Pezzella AT; Lew R; Traina V; Mathieu R J Thorac Cardiovasc Surg; 1989 Oct; 98(4):618-22. PubMed ID: 2796369 [TBL] [Abstract][Full Text] [Related]
11. Cephalothin prophylaxis in cardiac valve surgery. A prospective, double-blind comparison of two-day and six-day regimens. Goldmann DA; Hopkins CC; Karchmer AW; Abel RM; McEnany MT; Akins C; Buckley MJ; Moellering RC J Thorac Cardiovasc Surg; 1977 Mar; 73(3):470-9. PubMed ID: 402508 [TBL] [Abstract][Full Text] [Related]
12. Experience with expanded polytetrafluoroethylene (ePTFE Gore-Tex) surgical membrane for coronary artery grafting: does ePTFE surgical membrane predispose to postoperative mediastinitis? Kajiwara H; Hamada T; Ichikawa Y; Ishi M; Yamazaki I Artif Organs; 2004 Sep; 28(9):840-5. PubMed ID: 15320947 [TBL] [Abstract][Full Text] [Related]
13. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial. Alvarez JM; Jackson LR; Chatwin C; Smolich JJ J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294 [TBL] [Abstract][Full Text] [Related]
14. Trends in invasive treatment of single-vessel and double-vessel coronary disease. Arcidi JM; Powelson SW; King SB; Douglas JS; Jones EL; Craver JM; Landolt CC; Jackson ER; Hatcher CR; Guyton RA J Thorac Cardiovasc Surg; 1988 May; 95(5):773-81. PubMed ID: 2966265 [TBL] [Abstract][Full Text] [Related]
15. The effects of steroids on the occurrence of postoperative atrial fibrillation after coronary artery bypass grafting surgery: a prospective randomized trial. Prasongsukarn K; Abel JG; Jamieson WR; Cheung A; Russell JA; Walley KR; Lichtenstein SV J Thorac Cardiovasc Surg; 2005 Jul; 130(1):93-8. PubMed ID: 15999046 [TBL] [Abstract][Full Text] [Related]
16. Nifedipine as an adjunct to St. Thomas' Hospital cardioplegia. A double-blind, placebo-controlled, randomized clinical trial. Flameng W; De Meyere R; Daenen W; Sergeant P; Ngalikpima V; Geboers J; Suy R; Stalpaert G J Thorac Cardiovasc Surg; 1986 May; 91(5):723-31. PubMed ID: 3517508 [TBL] [Abstract][Full Text] [Related]
17. Postoperative chest wound infections in patients requiring coronary bypass. A controlled study evaluating prophylactic antibiotics. Sutherland RD; Martinez HE; Guynes WA; Miller L J Thorac Cardiovasc Surg; 1977 Jun; 73(6):944-7. PubMed ID: 300825 [TBL] [Abstract][Full Text] [Related]